US Broker Ratings

Insulet Corporation (PODD) Stock Analysis: Revenue Growth and Analyst Ratings Signal Promising Future

Investors with a keen eye on the healthcare sector may find Insulet Corporation (NASDAQ: PODD) to be a compelling prospect, thanks to its innovative advances in..

Thermo Fisher Scientific Inc (TMO) Stock Analysis: Strong Buy Ratings and a Promising 12.53% Upside

For investors with an eye on the healthcare sector, Thermo Fisher Scientific Inc (NYSE: TMO) presents an intriguing opportunity. With a market capitalization of $184.66 billion,..

Medtronic plc (MDT) Stock Analysis: A Healthcare Giant with 4.62% Potential Upside

Medtronic plc (NYSE: MDT), a titan in the medical devices sector, continues to be a compelling choice for investors seeking stability and growth in the healthcare..

Labcorp Holdings Inc. (LH) Stock Analysis: Exploring a Strong Buy Consensus with 8.45% Potential Upside

For individual investors eyeing opportunities in the healthcare sector, Labcorp Holdings Inc. (NYSE: LH) presents a compelling case. As a leader in Diagnostics & Research, Labcorp..

Mettler-Toledo International (MTD) Stock Analysis: Evaluating the 3.90% Revenue Growth and Analyst Ratings

Mettler-Toledo International Inc. (NYSE: MTD), a stalwart in the diagnostics and research industry, continues to capture investor attention with its robust market presence and consistent revenue..

Johnson & Johnson (JNJ) Stock Analysis: Navigating a 30.21% Return on Equity Amidst Healthcare Sector Dynamics

Johnson & Johnson (NYSE: JNJ), a stalwart in the healthcare sector, stands as a formidable entity in the drug manufacturing industry, boasting a market capitalization of..

The Cooper Companies, Inc. (COO) Stock Analysis: Unveiling a 27% Upside Potential

For investors looking to delve into the healthcare sector, The Cooper Companies, Inc. (NYSE: COO) presents a compelling opportunity, particularly with a potential upside of 27.31%...

Solventum Corporation (SOLV): Investor Outlook with a 21.41% Upside Potential

Solventum Corporation (NYSE: SOLV), a key player in the healthcare sector, has been gaining attention for its diverse portfolio of solutions that cater to critical customer..

Summit Therapeutics Inc. (SMMT) Stock Analysis: Unpacking a 31.65% Potential Upside for Investors

Summit Therapeutics Inc. (NASDAQ: SMMT) is a name that has increasingly caught the attention of investors within the biotechnology sector. With its robust market capitalization of..

Tenet Healthcare Corporation (THC) Stock Analysis: Strong Buy Ratings and a 14.83% Upside Potential

Tenet Healthcare Corporation (NYSE: THC) stands as a formidable player in the U.S. healthcare sector, primarily operating within the medical care facilities industry. With a substantial..

Cencora, Inc. (COR) Stock Analysis: 13.82% Potential Upside and Strong Buy Ratings Fuel Investor Interest

Cencora, Inc. (NYSE: COR), formerly known as AmerisourceBergen Corporation, presents a compelling opportunity for investors looking to tap into the robust healthcare sector. With a market..

Natera, Inc. (NTRA): Investor Outlook on a Diagnostics Leader with a 21.33% Potential Upside

Natera, Inc. (NASDAQ: NTRA), a prominent player in the diagnostics and research industry, offers a compelling investment opportunity for those eyeing the healthcare sector. With a..

The Cigna Group (CI) Stock Analysis: Exploring a 23.92% Upside Potential for Investors

The Cigna Group (NYSE: CI), a stalwart in the healthcare sector, presents an intriguing prospect for individual investors, with analysts predicting a potential upside of nearly..

IQVIA Holdings, Inc. (IQV) Stock Analysis: Insights into a Healthcare Giant with 11.49% Potential Upside

IQVIA Holdings, Inc. (IQV), a prominent player in the healthcare sector, continues to capture investor attention with its robust market presence and promising growth indicators. With..

BeOne Medicines Ltd. (ONC) Stock Analysis: Is This Swiss Biotech Giant Worth Your Investment?

For investors eyeing the biotechnology sector, BeOne Medicines Ltd. (ONC) emerges as a compelling opportunity, boasting a substantial market cap of $38.83 billion. This Swiss-based oncology..

BioNTech SE (BNTX) Stock Analysis: 21% Potential Upside Amid Strong Buy Consensus

BioNTech SE, a prominent player in the biotechnology sector, has been a focal point for investors due to its pioneering work in immunotherapies for cancer and..

Royalty Pharma plc (RPRX) Stock Analysis: Exploring a 19% Potential Upside in Biopharmaceutical Royalties

Investors looking for exposure in the biopharmaceutical sector might find Royalty Pharma plc (NASDAQ: RPRX) an intriguing option, particularly with the potential for a 19.08% upside...

AstraZeneca PLC (AZN) Investor Outlook: Analyzing Growth Potential with a 9.40% Upside

AstraZeneca PLC (AZN), a titan in the healthcare sector, is renowned for its robust portfolio of prescription medicines that cater to a broad spectrum of medical..

Cardinal Health, Inc. (CAH): Investor Outlook on Strong Analyst Buy Ratings with 20.62% Potential Upside

Cardinal Health, Inc. (NYSE: CAH) stands as a formidable player in the healthcare sector, specifically within the medical distribution industry. With a substantial market capitalization of..

Edwards Lifesciences Corporatio (EW)

⚠️ No article content returned.

..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds